<DOC>
	<DOCNO>NCT03015090</DOCNO>
	<brief_summary>The aim study determine whether common CYP1A2 gene polymorphism effect metabolism theophylline Han Uygur Patients chronic obstructive pulmonary disease patient .</brief_summary>
	<brief_title>Association Study Between CYP1A2 Gene Polymorphisms Metabolism Theophylline</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Aged 1875 year , Weight 4080kg COPD patient , male female ; regularly visit hospital ; take sustainedrelease preparation theophylline continuously least 2 week Patients renal hepatic dysfunction ; Patients congestive heart failure ; Patients hypothyroidism hyperthyroidism ; Patients currently take drug likely effect theophylline metabolism take drug precede week ; Patients extreme obesity Patients severe Chronic Obstructive Pulmonary Disease ( COPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>COPD</keyword>
	<keyword>CYP1A2</keyword>
	<keyword>Theophylline</keyword>
</DOC>